Home > Clinical Trials

Saved trials

COMPLETED
NCT02401815
CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors
51 Enrollment(s)
6 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Gastrointestinal Stromal Tumors
NOT_YET_RECRUITING
NCT06864052
The Incidence of New-brain Lesions on Brain MRI and Safety Between Edoxaban and Apixaban in Patients with Stroke and Nonvalvular Atrial Fibrillation
400 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (NA)
Stroke
Atrial Fibrillation
연구종결
KCT0010330
비타민K비의존성 경구용 항응고제를 사용하는 비판막성 심방세동 환자에서 올메사르탄 병용 사용군 대비 텔미사르탄 병용 사용군의 출혈 위험을 평가하는 후향적 코호트 연구
18,252 Enrollment(s)
1 Study location(s)
관찰연구 (None)
연구종결
KCT0009530
건강한 성인을 대상으로 보중익기탕, 청상견통탕 및 이진탕이 에독사반의 약동학 및 약력학에 미치는 영향을 평가하기 위한 임상시험
30 Enrollment(s)
1 Study location(s)
중재연구 (None)
RECRUITING
NCT06102824
Organoid-based Functional Precision Therapy for Advanced Breast Cancer
252 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
HER2-negative Breast Cancer


Advanced Breast Cancer
RECRUITING
NCT05824975
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
358 Enrollment(s)
11 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Advanced Solid Tumor
Metastatic Solid Tumor
Soft Tissue Sarcoma (STS)
Platinum-resistant Ovarian Cancer (PROC)
Hepatocellular Carcinoma (HCC)
Colorectal Cancer (CRC)
HER2 Negative Breast Cancer
Cutaneous Melanoma
Renal Cell Carcinoma (RCC)
COMPLETED
NCT04989816
Study of T-DXd Monotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma Who Have Received 2 or More Prior Regimens
95 Enrollment(s)
24 Study location(s)
INTERVENTIONAL (PHASE2)
Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
RECRUITING
NCT05965479
Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer
25 Enrollment(s)
14 Study location(s)
INTERVENTIONAL (PHASE2)
Gastrooesophageal Cancer